CCDC50 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.884500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.372610E-01
Normal-vs-Stage2
5.411900E-02
Normal-vs-Stage3
3.970300E-02
Normal-vs-Stage4
5.080600E-01
Stage1-vs-Stage2
9.179800E-01
Stage1-vs-Stage3
1.512190E-01
Stage1-vs-Stage4
6.750400E-01
Stage2-vs-Stage3
1.273210E-01
Stage2-vs-Stage4
5.632400E-01
Stage3-vs-Stage4
2.629600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.633500E-02
Normal-vs-AfricanAmerican
3.541000E-01
Normal-vs-Asian
1.369970E-01
Caucasian-vs-AfricanAmerican
5.922200E-01
Caucasian-vs-Asian
6.197800E-01
AfricanAmerican-vs-Asian
5.909800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.632000E-02
Normal-vs-Female
6.534000E-02
Male-vs-Female
2.803000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.399620E-01
Normal-vs-Age(41-60Yrs)
1.301650E-01
Normal-vs-Age(61-80Yrs)
3.409600E-02
Normal-vs-Age(81-100Yrs)
9.651700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.951800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.735600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.341200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.281510E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.318800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.853400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.174000E-02
Normal-vs-Daily Drinker
3.943400E-03
Normal-vs-Weekly Drinker
8.700300E-02
Normal-vs-Occasional Drinker
7.494100E-02
Normal-vs-Social Drinker
3.994000E-01
Non Drinker-vs-Daily Drinker
3.936000E-01
Non Drinker-vs-Weekly Drinker
8.276400E-01
Non Drinker-vs-Occasional Drinker
4.969400E-01
Non Drinker-vs-Social Drinker
6.998000E-02
Daily Drinker-vs-Weekly Drinker
3.758800E-01
Daily Drinker-vs-Occasional Drinker
1.512200E-01
Daily Drinker-vs-Social Drinker
4.115600E-02
Weekly Drinker-vs-Occasional Drinker
7.403600E-01
Weekly Drinker-vs-Social Drinker
2.270200E-01
Occasional Drinker-vs-Social Drinker
2.800000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.066010E-01
Normal-vs-Grade 2
4.902300E-03
Normal-vs-Grade 3
2.197900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.756360E-01
Grade 1-vs-Grade 3
1.114390E-01
Grade 1-vs-Grade 4
1.066010E-01
Grade 2-vs-Grade 3
5.778200E-01
Grade 2-vs-Grade 4
4.902300E-03
Grade 3-vs-Grade 4
2.197900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.130100E-02
Normal-vs-NonDiabetic
3.109800E-02
Diabetic-vs-NonDiabetic
8.292600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.474100E-02
Normal-vs-NoPancreatitis
2.577500E-02
Pancreatitis-vs-NoPancreatitis
9.865800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.630400E-02
Normal-vs-N1
4.708400E-02
N0-vs-N1
4.404200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.544100E-02
Normal-vs-TP53-NonMutant
9.121500E-02
TP53-Mutant-vs-TP53-NonMutant
8.568400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
